Response to and Survival after First-Line FOLFIRINOX or Gemcitabine/Nab-Paclitaxel for Localized Pancreatic Ductal Adenocarcinoma. (2021)

Record Type:: Journal Article
Title:: Response to and Survival after First-Line FOLFIRINOX or Gemcitabine/Nab-Paclitaxel for Localized Pancreatic Ductal Adenocarcinoma. (2021)
Main Title:: Response to and Survival after First-Line FOLFIRINOX or Gemcitabine/Nab-Paclitaxel for Localized Pancreatic Ductal Adenocarcinoma
Authors:: Perri, G.
Prakash, L.
Varadhachary, G.R.
Koay, E.J.
Kim, M.
Ikoma, N.
Tzeng, C.
Lee, J.E.
Katz, M.H.
Abstract:
Is Part Of:: HPB. Volume 23(2021)Supplement 1
Journal:: HPB
Issue:: Volume 23(2021)Supplement 1
Issue Display:: Volume 23, Issue 1 (2021)
Year:: 2021
Volume:: 23
Issue:: 1
Issue Sort Value:: 2021-0023-0001-0000
Page Start:: S10
Page End:
Publication Date:: 2021
Subjects:: Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005
Journal URLs:: https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1016/j.hpb.2020.11.027 ↗
Languages:: English
ISSNs:: 1365-182X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 16385.xml